Blue Fin Capital, Inc. Baxter International Inc Transaction History

Blue Fin Capital, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$78.33 - $90.73 $190,890 - $221,109	-2,437 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$78.66 - $94.14 $8,495 - $10,167	-108 Reduced 4.24%	2,437 $209,000
Q1 2020 Apr 28, 2020	SELL	$71.57 - $93.3 $2,934 - $3,825	-41 Reduced 1.59%	2,545 $206,000
Q3 2019 Nov 07, 2019	SELL	$81.4 - $89.78 $10,582 - $11,671	-130 Reduced 4.79%	2,586 $226,000
Q1 2019 Apr 23, 2019	SELL	$64.48 - $81.31 $25,792 - $32,524	-400 Reduced 12.84%	2,716 $220,000

Q2 2018 Aug 06, 2018	SELL	$63.43 - $75.41 $6,343 - $7,541	-100 Reduced 3.11%	3,116 $230,000
Q1 2018 May 07, 2018	SELL	$62.56 - $72.26 $3,128 - $3,613	-50 Reduced 1.53%	3,216 $209,000
Q3 2017 Oct 11, 2017	BUY	$59.5 - $64.61 $194,327 - $211,016	3,266	3,266 $204,000

1,025

442M

4.22M

2.52M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Blue Fin Capital, Inc. with notifications on news.